Tempus AI posts $1.27B in 2025 revenue, up ~83% YoY; total contract value tops $1.1B 👌
Health technology company Tempus AI (TEM) reported 2025 revenue of ~$1.27 billion, representing ~83% growth year-over-year, including ~30% organic growth (excluding Ambry). Diagnostics revenue came in at ~$955 million, representing ~111% growth year-over-year, driven by oncology volume growth of ~26% and hereditary volume growth of ~29%. Data and applications revenue stood at ~$316 million, representing ~31% growth year-over-year, driven by ~38% growth in Insights. In addition, Tempus AI (TEM) announced a record total contract value of >$1.1 billion as of December 31, 2025.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
$TEM
Tempus AI posts $1.27B in 2025 revenue, up ~83% YoY; total contract value tops $1.1B 👌
Health technology company Tempus AI (TEM) reported 2025 revenue of ~$1.27 billion, representing ~83% growth year-over-year, including ~30% organic growth (excluding Ambry).
Diagnostics revenue came in at ~$955 million, representing ~111% growth year-over-year, driven by oncology volume growth of ~26% and hereditary volume growth of ~29%.
Data and applications revenue stood at ~$316 million, representing ~31% growth year-over-year, driven by ~38% growth in Insights.
In addition, Tempus AI (TEM) announced a record total contract value of >$1.1 billion as of December 31, 2025.